Publications by authors named "Kimberly Shao"

Periocular and ocular surface nonmelanoma malignancies, including basal cell carcinoma (BCC), squamous cell carcinomas (SCC), and ocular surface squamous neoplasia (OSSN), are rare, but their management requires special considerations. The most common periocular malignancy is BCC, which constitutes 80% to 96% of tumors, followed by SCC, which represents 5% to 10% of tumors. OSSN represents a spectrum of diseases that encompass dysplastic alteration to the squamous epithelium of the eye.

View Article and Find Full Text PDF

There is growing interest in the development of a skin classification system that captures the world's diverse population. The Fitzpatrick skin classification scale is used both clinically and in research settings to determine an individual's skin color. With the high global burden of skin sensitivity (atopic dermatitis, keloid formation, etc), there is a need for a skin classification system that takes into consideration an individual's reaction to environmental insults and injuries.

View Article and Find Full Text PDF

Objective: Racial and ethnic health disparities affect the diagnosis and management of melanoma and nonmelanoma skin cancers, leading to deleterious outcomes. Non-Hispanic White patients make up the majority of skin cancers cases, yet racial and ethnic minorities have poorer prognoses and outcomes. The skin cancer literature is fragmented with regards to potential contributors to these healthcare disparities.

View Article and Find Full Text PDF

Background: The relationship of postoperative facial scar assessments among patients, physicians, and societal onlookers is not clearly defined.

Objective: To identify differences in perceived scar outcomes by different stakeholders.

Methods And Materials: Retrospective cohort study at a single Mohs micrographic surgery (MMS) center during which scars were assessed by: patients, physicians, and medical student observers not involved in patients' care using the Patient and Observer Scar Assessment Scale (v.

View Article and Find Full Text PDF

Racial and ethnic disparities in dermatology negatively affect outcomes such as mortality and quality of life. Dermatologists and dermatologic surgeons should be familiar with disease-specific inequities that may influence their practice. The second article in this 2-part continuing medical education series highlights gaps in frequency, clinical presentation, management, and outcomes by race and ethnicity.

View Article and Find Full Text PDF

Racial or ethnic disparities are prevalent in the field of dermatology. Part 1 of this continuing medical education series aims to elucidate contributors to racial and ethnic disparities within dermatology and highlight potential actionable steps to combat these disparities. We review access to care, workforce diversity, cultural competency, implicit bias, dermatologic education material, patient education, and clinical research.

View Article and Find Full Text PDF

Nonmelanoma skin cancer (NMSC), the most widely diagnosed cancer in the United States, is rising in incidence despite public health and educational campaigns that highlight the importance of sun avoidance. It is,therefore, important to establish other modifiable risk factors that may be contributing to this increase. There is a growing body of evidence in the literature suggesting certain nutrients may have protective or harmful effects on NMSC.

View Article and Find Full Text PDF

Urticaria is a distressing dermatologic condition for many. Although the wheals of urticaria are characteristically evanescent, lasting less than 24 hours, patients tend to have recurrent episodes. Hives that last less than 6 weeks are considered acute urticaria.

View Article and Find Full Text PDF
Article Synopsis
  • There is a growing interest among the public and health care providers regarding the medical benefits of cannabis, particularly for dermatological issues.
  • Research indicates that cannabis may help regulate pain, itching, and inflammation, making it a potential treatment option for various skin conditions.
  • The current literature on cannabinoids in dermatology is still developing, with future research needed on their effects on skin cancer, acne, psoriasis, and other skin-related ailments.
View Article and Find Full Text PDF
Article Synopsis
  • Early identification of skin issues related to alcohol and drug use is crucial for proper diagnosis and treatment, as these conditions can lead to serious health problems.
  • Alcohol misuse can cause skin-related symptoms like jaundice, itching, and risk factors for skin cancer, while also affecting other health issues such as nutritional deficiencies and various skin diseases.
  • Illicit drug use leads to a range of cutaneous problems, including infections and scarring, highlighting the need for dermatologists to recognize these signs to better support patients struggling with addiction.
View Article and Find Full Text PDF

The natural evolution of facial scars has not been well described. Identifying factors that correlate with optimal scar healing may help patients and physicians during the perioperative period. A retrospective study of 108 facial skin cancer patient scars was performed.

View Article and Find Full Text PDF

The United States Preventive Services Task Force (USPSTF) 2016 recommendation for skin cancer screening in asymptomatic healthy adults concluded that current evidence is "insufficient to assess the balance and harms of visual skin examination." One contributing factor leading to the insufficient grade was a concern for cosmetic harms resulting from unnecessary biopsies or excisions. This commentary briefly highlights the pertinent studies and currently accepted methods for pigmented lesion biopsy.

View Article and Find Full Text PDF

PD-1 (programmed cell death-1) inhibitors, used to treat metastatic melanoma and other malignancies, are associated with development of immune-related adverse events in the skin. Such reactions include morbilliform eruptions, vitiligo, alopecia areata and bullous pemphigoid. In this report, we describe a patient who developed a lupus-like cutaneous reaction in the setting of pembrolizumab therapy for metastatic melanoma, adding to the spectrum of reactions which may be observed in association with PD-1 inhibitor therapy.

View Article and Find Full Text PDF